[1]
Cole LA, Laidler LL. Inherited human chorionic gonadotropin. The Journal of reproductive medicine. 2010 Mar-Apr:55(3-4):99-102
[PubMed PMID: 20506668]
[2]
Cole LA, Butler S. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. The Journal of reproductive medicine. 2002 Jun:47(6):433-44
[PubMed PMID: 12092011]
[3]
Kohorn EI. What we know about low-level hCG: definition, classification and management. The Journal of reproductive medicine. 2004 Jun:49(6):433-7
[PubMed PMID: 15283049]
[4]
Faiman C,Ryan RJ,Zwirek SJ,Rubin ME, Serum FSH and HCG during human pregnancy and puerperium. The Journal of clinical endocrinology and metabolism. 1968 Sep;
[PubMed PMID: 5679995]
[5]
Cole LA. Biological functions of hCG and hCG-related molecules. Reproductive biology and endocrinology : RB&E. 2010 Aug 24:8():102. doi: 10.1186/1477-7827-8-102. Epub 2010 Aug 24
[PubMed PMID: 20735820]
[6]
Berndt S, Blacher S, Perrier d'Hauterive S, Thiry M, Tsampalas M, Cruz A, Péqueux C, Lorquet S, Munaut C, Noël A, Foidart JM. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. The Journal of clinical endocrinology and metabolism. 2009 Nov:94(11):4567-74. doi: 10.1210/jc.2009-0443. Epub 2009 Oct 16
[PubMed PMID: 19837939]
[7]
Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. British journal of cancer. 2000 May:82(9):1553-6
[PubMed PMID: 10789723]
[8]
Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecologic oncology. 2006 Aug:102(2):145-50
[PubMed PMID: 16631920]
[9]
Toth P, Li X, Rao CV, Lincoln SR, Sanfilippo JS, Spinnato JA 2nd, Yussman MA. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. The Journal of clinical endocrinology and metabolism. 1994 Jul:79(1):307-15
[PubMed PMID: 8027246]
[10]
Iles RK. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Molecular and cellular endocrinology. 2007 Jan 2:260-262():264-70
[PubMed PMID: 17069968]
[11]
Toth P,Lukacs H,Gimes G,Sebestyen A,Pasztor N,Paulin F,Rao CV, Clinical importance of vascular LH/hCG receptors--a review. Reproductive biology. 2001 Nov;
[PubMed PMID: 14666164]
[12]
Rao CV. Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta endocrinologica. 1979 Apr:90(4):696-710
[PubMed PMID: 34964]
[13]
Strott CA, Yoshimi T, Ross GT, Lipsett MB. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. The Journal of clinical endocrinology and metabolism. 1969 Sep:29(9):1157-67
[PubMed PMID: 5808525]
[14]
Akoum A,Metz CN,Morin M, Marked increase in macrophage migration inhibitory factor synthesis and secretion in human endometrial cells in response to human chorionic gonadotropin hormone. The Journal of clinical endocrinology and metabolism. 2005 May;
[PubMed PMID: 15687332]
[15]
Herrmann-Lavoie C, Rao CV, Akoum A. Chorionic gonadotropin down-regulates the expression of the decoy inhibitory interleukin 1 receptor type II in human endometrial epithelial cells. Endocrinology. 2007 Nov:148(11):5377-84
[PubMed PMID: 17702847]
[16]
Matsuura T, Sugimura M, Iwaki T, Ohashi R, Kanayama N, Nishihira J. Anti-macrophage inhibitory factor antibody inhibits PMSG-hCG-induced follicular growth and ovulation in mice. Journal of assisted reproduction and genetics. 2002 Dec:19(12):591-5
[PubMed PMID: 12503892]
[17]
Kamada M, Ino H, Naka O, Irahara M, Daitoh T, Mori K, Maeda N, Maegawa M, Hirano K, Aono T. Immunosuppressive 30-kDa protein in urine of pregnant women and patients with trophoblastic diseases. European journal of obstetrics, gynecology, and reproductive biology. 1993 Aug:50(3):219-25
[PubMed PMID: 8262299]
[18]
Majumdar S, Bapna BC, Mapa MK, Gupta AN, Devi PK, Subrahmanyam D. Pregnancy specific proteins: suppression of in vitro blastogenic response to mitogen by these proteins. International journal of fertility. 1982:27(2):66-9
[PubMed PMID: 6126448]
[19]
CEDARD L, VARANGOT J, YANNOTTI S. [The metabolism of estrogens in human placentas artificially maintained in survival by perfusion in vitro]. Comptes rendus hebdomadaires des seances de l'Academie des sciences. 1962 Mar 5:254():1870-1
[PubMed PMID: 13877595]
[20]
Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 1993 May:132(5):2262-70
[PubMed PMID: 8477671]
[21]
Visconti F, Quaresima P, Chiefari E, Caroleo P, Arcidiacono B, Puccio L, Mirabelli M, Foti DP, Di Carlo C, Vero R, Brunetti A. First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes Mellitus. International journal of environmental research and public health. 2019 Sep 28:16(19):. doi: 10.3390/ijerph16193654. Epub 2019 Sep 28
[PubMed PMID: 31569431]
[22]
Barjaktarovic M, Korevaar TI, Jaddoe VW, de Rijke YB, Visser TJ, Peeters RP, Steegers EA. Human chorionic gonadotropin (hCG) concentrations during the late first trimester are associated with fetal growth in a fetal sex-specific manner. European journal of epidemiology. 2017 Feb:32(2):135-144. doi: 10.1007/s10654-016-0201-3. Epub 2016 Oct 5
[PubMed PMID: 27709449]
[23]
Cavaliere A, Ermito S, Dinatale A, Pedata R. Management of molar pregnancy. Journal of prenatal medicine. 2009 Jan:3(1):15-7
[PubMed PMID: 22439034]
[24]
Brouillet S, Murthi P, Hoffmann P, Salomon A, Sergent F, De Mazancourt P, Dakouane-Giudicelli M, Dieudonné MN, Rozenberg P, Vaiman D, Barbaux S, Benharouga M, Feige JJ, Alfaidy N. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cellular and molecular life sciences : CMLS. 2013 Feb:70(3):511-25. doi: 10.1007/s00018-012-1141-z. Epub 2012 Sep 2
[PubMed PMID: 22941044]
Level 3 (low-level) evidence